Concepedia

Michael K. Wong

MK

Statistics

Publications

74

Citations

5.6K

H-Index

36

Active since

1984

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of Southern California

University of California, San Francisco

Duke Medical Center

UPMC Hillman Cancer Center

Michael K. Wong is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and cancer immunotherapy.

Publications per year

1984–2025

74

Publications

74

Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response

Christine N. Spencer, Jennifer L. McQuade, Vancheswaran Gopalakrishnan et al. · Science · 2021 · 879 citations · Full text

Life Sciences, Immunology, Oncology +17

Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

Rodabe N. Amaria, Sangeetha M. Reddy, Hussein A. Tawbi et al. · Nature Medicine · 2018 · 826 citations · Full text

Life Sciences, Immunology, Oncology +14

Neoadjuvant relatlimab and nivolumab in resectable melanoma

Rodabe N. Amaria, Michael A. Postow, Elizabeth M. Burton et al. · Nature · 2022 · 332 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial

Rodabe N. Amaria, Peter A. Prieto, Michael T. Tetzlaff et al. · The Lancet Oncology · 2018 · 290 citations

Medicine, Oncology, Surgery +14

Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis

Daniel H. Johnson, Chrystia M. Zobniw, Van Anh Trinh et al. · Journal for ImmunoTherapy of Cancer · 2018 · 192 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +14

1–5 of 74